These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 19876075)

  • 1. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
    Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
    J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
    Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
    J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
    Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
    Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.
    Lin YC; Sheng WH; Chen YC; Chang SC; Hsia KC; Li SY
    Int J Antimicrob Agents; 2010 May; 35(5):439-43. PubMed ID: 20106635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
    Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
    Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH; Qi C; Warren JR; Postelnick MJ; Zembower T; Obias A; Noskin GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
    Lu PL; Huang LY; Lian ST; Chang K; Lin CL; Hwang IJ; Chiang WG; Chen YH; Lin SF; Siu LK
    Int J Antimicrob Agents; 2008 May; 31(5):463-6. PubMed ID: 18359613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
    Park YK; Choi JY; Jung SI; Park KH; Lee H; Jung DS; Heo ST; Kim SW; Chang HH; Cheong HS; Chung DR; Peck KR; Song JH; Ko KS
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):389-95. PubMed ID: 19631092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
    Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
    J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
    Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
    Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.